Loading…

Revascularization as a means of reducing sudden death

From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA a...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 1986-05, Vol.7 Suppl A, p.181-186
Main Authors: Hugenholtz, P G, Serruys, P W, Laird-Meeter, K, Roelandt, J R
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 186
container_issue
container_start_page 181
container_title European heart journal
container_volume 7 Suppl A
creator Hugenholtz, P G
Serruys, P W
Laird-Meeter, K
Roelandt, J R
description From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76894542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76894542</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143</originalsourceid><addsrcrecordid>eNotj8tKxDAUQLNQxnH0E4Ss3BXyatIsZfAFA4I4MLtyJ7nRSJvWphH06x2wq7M5HDhnZM24rSutm8MFucz5kzHWaK5XZCWs4pKJNalf8RuyKx1M8RfmOCQKmQLtEVKmQ6AT-uJieqe5eI-JeoT544qcB-gyXi_ckP3D_dv2qdq9PD5v73bVKJieq2DRGlSCO3EEdNL6wHgI6KAOwpxKqE0AAx6EB44hGG49Oisb1Bq4khty-98dp-GrYJ7bPmaHXQcJh5JboxuraiVO4s0ilmOPvh2n2MP00y6f8g8BE080</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76894542</pqid></control><display><type>article</type><title>Revascularization as a means of reducing sudden death</title><source>Oxford University Press Archive</source><creator>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</creator><creatorcontrib>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</creatorcontrib><description>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</description><identifier>ISSN: 0195-668X</identifier><identifier>PMID: 2941302</identifier><language>eng</language><publisher>England</publisher><subject>Angina Pectoris - therapy ; Angioplasty, Balloon ; Coronary Disease - drug therapy ; Coronary Disease - surgery ; Coronary Disease - therapy ; Coronary Vessels ; Death, Sudden ; Humans ; Myocardial Infarction - therapy ; Myocardial Revascularization ; Streptokinase - administration &amp; dosage ; Streptokinase - therapeutic use</subject><ispartof>European heart journal, 1986-05, Vol.7 Suppl A, p.181-186</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2941302$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hugenholtz, P G</creatorcontrib><creatorcontrib>Serruys, P W</creatorcontrib><creatorcontrib>Laird-Meeter, K</creatorcontrib><creatorcontrib>Roelandt, J R</creatorcontrib><title>Revascularization as a means of reducing sudden death</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</description><subject>Angina Pectoris - therapy</subject><subject>Angioplasty, Balloon</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - surgery</subject><subject>Coronary Disease - therapy</subject><subject>Coronary Vessels</subject><subject>Death, Sudden</subject><subject>Humans</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Revascularization</subject><subject>Streptokinase - administration &amp; dosage</subject><subject>Streptokinase - therapeutic use</subject><issn>0195-668X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><recordid>eNotj8tKxDAUQLNQxnH0E4Ss3BXyatIsZfAFA4I4MLtyJ7nRSJvWphH06x2wq7M5HDhnZM24rSutm8MFucz5kzHWaK5XZCWs4pKJNalf8RuyKx1M8RfmOCQKmQLtEVKmQ6AT-uJieqe5eI-JeoT544qcB-gyXi_ckP3D_dv2qdq9PD5v73bVKJieq2DRGlSCO3EEdNL6wHgI6KAOwpxKqE0AAx6EB44hGG49Oisb1Bq4khty-98dp-GrYJ7bPmaHXQcJh5JboxuraiVO4s0ilmOPvh2n2MP00y6f8g8BE080</recordid><startdate>19860501</startdate><enddate>19860501</enddate><creator>Hugenholtz, P G</creator><creator>Serruys, P W</creator><creator>Laird-Meeter, K</creator><creator>Roelandt, J R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19860501</creationdate><title>Revascularization as a means of reducing sudden death</title><author>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Angina Pectoris - therapy</topic><topic>Angioplasty, Balloon</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - surgery</topic><topic>Coronary Disease - therapy</topic><topic>Coronary Vessels</topic><topic>Death, Sudden</topic><topic>Humans</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Revascularization</topic><topic>Streptokinase - administration &amp; dosage</topic><topic>Streptokinase - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hugenholtz, P G</creatorcontrib><creatorcontrib>Serruys, P W</creatorcontrib><creatorcontrib>Laird-Meeter, K</creatorcontrib><creatorcontrib>Roelandt, J R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hugenholtz, P G</au><au>Serruys, P W</au><au>Laird-Meeter, K</au><au>Roelandt, J R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revascularization as a means of reducing sudden death</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>1986-05-01</date><risdate>1986</risdate><volume>7 Suppl A</volume><spage>181</spage><epage>186</epage><pages>181-186</pages><issn>0195-668X</issn><abstract>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</abstract><cop>England</cop><pmid>2941302</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 1986-05, Vol.7 Suppl A, p.181-186
issn 0195-668X
language eng
recordid cdi_proquest_miscellaneous_76894542
source Oxford University Press Archive
subjects Angina Pectoris - therapy
Angioplasty, Balloon
Coronary Disease - drug therapy
Coronary Disease - surgery
Coronary Disease - therapy
Coronary Vessels
Death, Sudden
Humans
Myocardial Infarction - therapy
Myocardial Revascularization
Streptokinase - administration & dosage
Streptokinase - therapeutic use
title Revascularization as a means of reducing sudden death
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revascularization%20as%20a%20means%20of%20reducing%20sudden%20death&rft.jtitle=European%20heart%20journal&rft.au=Hugenholtz,%20P%20G&rft.date=1986-05-01&rft.volume=7%20Suppl%20A&rft.spage=181&rft.epage=186&rft.pages=181-186&rft.issn=0195-668X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E76894542%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76894542&rft_id=info:pmid/2941302&rfr_iscdi=true